SLNCF
SILENCE THERAPEUTICS ORD by Silence Therapeutics, Plc. (SLNCF)
$00
About SILENCE THERAPEUTICS ORD by Silence Therapeutics, Plc. (SLNCF)
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.25
52 Week Low
$0.50
Market cap
283.4M
Dividend yield
0.00%
Volume
--
Avg. volume
160
P/E ratio
-3.20
SILENCE THERAPEUTICS ORD by Silence Therapeutics, Plc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.25
52 Week Low
$0.50
Market cap
283.4M
Dividend yield
0.00%
Volume
--
Avg. volume
160
P/E ratio
-3.20